Cargando…
Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371756/ https://www.ncbi.nlm.nih.gov/pubmed/37502537 http://dx.doi.org/10.1155/2023/9783232 |
| _version_ | 1785078219566743552 |
|---|---|
| author | Imaging, Contrast Media & Molecular |
| author_facet | Imaging, Contrast Media & Molecular |
| author_sort | Imaging, Contrast Media & Molecular |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10371756 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103717562023-07-27 Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia Imaging, Contrast Media & Molecular Contrast Media Mol Imaging Retraction Hindawi 2023-07-19 /pmc/articles/PMC10371756/ /pubmed/37502537 http://dx.doi.org/10.1155/2023/9783232 Text en Copyright © 2023 Contrast Media & Molecular Imaging. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Imaging, Contrast Media & Molecular Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia |
| title | Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia |
| title_full | Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia |
| title_fullStr | Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia |
| title_full_unstemmed | Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia |
| title_short | Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia |
| title_sort | retracted: the clinical efficacy and economic benefits of recombinant human thrombopoietin for the treatment of chemotherapy or chemoradiotherapy-induced thrombocytopenia |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371756/ https://www.ncbi.nlm.nih.gov/pubmed/37502537 http://dx.doi.org/10.1155/2023/9783232 |
| work_keys_str_mv | AT imagingcontrastmediamolecular retractedtheclinicalefficacyandeconomicbenefitsofrecombinanthumanthrombopoietinforthetreatmentofchemotherapyorchemoradiotherapyinducedthrombocytopenia |